MSC-Derived Exosome Product
Invitrx EX-MSC is an allogeneic Wharton's Jelly MSC-derived exosome product. Invitrx EX-MSC is manufactured using our proprietary isolation and purification technologies. The natural cell origin of exosomes enables improved efficacy, biocompatibility, and reduced immunogenicity. Invitrx EX-MSC extensive characterizations such consistency and potency assays provide assurance of quality throughout the production process.
Dedication to Excellence
Invitrx Therapeutics headquartered in Orange County California is an international biotechnology company with over 15 years of experience in the development of clinical products. Invitrx was established in 2003 and it has been a pioneer in regenerative stem cell therapies.
Invitra EX™ is manufactured from umbilical cords from full-term deliveries. All donors are pre-screened and undergo comprehensive testing which includes the following:
- Behavioral risk assessment
- Physical assessment
- Donor medical history
- Communicable disease testingInfectious disease testing is performed at a certified laboratory in accordance with the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and 42 CFR part 493.